Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million public offering.
- Nuvve Holding Corp. (NASDAQ: NVVE) shares gained 30% to $0.1931 in pre-market trading after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million shares of common stock at a price to the public of $0.14 per share.
- NextPlat Corp (NASDAQ: NXPL) shares rose 28.6% to $2.26 in pre-market trading after gaining over 3% on Tuesday.
- Bruush Oral Care Inc. (NASDAQ: BRSH) rose 25.7% to $0.4832 in pre-market trading after gaining around 4% on Tuesday.
- LumiraDx Limited (NASDAQ: LMDX) gained 24.7% to $0.1933 in pre-market trading after dipping around 44% on Tuesday.
- Cognition Therapeutics, Inc. (NASDAQ: CGTX) shares rose 16.5% to $1.41 in pre-market trading. Cognition Therapeutics presented complete EEG findings from SEQUEL study of CT1812 in mild-to-moderate Alzheimer's disease at the Clinical Trials on Alzheimer’s Disease (CTAD) conference.
- BioVie Inc. (NASDAQ: BIVI) shares climbed 16.4% to $3.90 in pre-market trading after gaining around 3% on Tuesday.
- Sonendo, Inc. (NYSE: SONX) shares jumped 15.2% to $0.2650 in pre-market trading after falling over 23% on Tuesday. Sonendo recently announced preliminary revenue results for the third quarter.
- Recon Technology, Ltd. (NASDAQ: RCON) rose 12.1% to $0.2988 in pre-market trading.
- Microsoft Corporation (NASDAQ: MSFT) shares rose 3.6% to $342.51 in pre-market trading as the company posted stronger-than-expected results for its fiscal first quarter on Tuesday. Piper Sandler maintained Microsoft with an Overweight and raised the price target from $400 to $425.
- Appreciate Holdings, Inc. (NASDAQ: SFR) dipped 32.7% to $0.1001 in pre-market trading. Appreciate Holdings received a notice from Nasdaq regarding delisting.
- Intrusion Inc. (NASDAQ: INTZ) shares fell 28.1% to $0.2479 in pre-market trading after declining over 7% on Tuesday.
- Tharimmune, Inc. (NASDAQ: THAR) shares fell 25.1% to $0.1888 in pre-market trading after jumping 34% on Tuesday.
- InMed Pharmaceuticals Inc. (NASDAQ: INM) shares fell 23.2% to $0.76 in pre-market trading. InMed Pharmaceuticals announced a $5.2 million private placement and preferred investment option exercise priced at-the-market under Nasdaq rules.
- Vicor Corporation (NASDAQ: VICR) fell 20.8% to $42.11 in pre-market trading after reporting results for the third quarter.
- Alphatec Holdings, Inc. (NASDAQ: ATEC) shares fell 14.5% to $10.96 in pre-market trading after the company priced underwritten public offering of 14.3 million common shares at $10.50 per share.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) fell 13.8% to $1.56 in pre-market after declining 12% on Tuesday.
- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) shares fell 12.5% to $1.05 in pre-market trading. Ascent Solar shares jumped 22% on Tuesday after the company announced the initial concept paper submitted for DE-FOA-000305 has been reviewed and received an "Encouraged" decision from the DOE.
- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) fell 10.2% to $2.02 in pre-market trading. Lipella Pharmaceuticals announced a $2 million private placement priced at-the-market under Nasdaq rules.
- Alphabet Inc. (NASDAQ: GOOGL) shares fell 6.8% to $129.42 in pre-market trading. Alphabet reported better-than-expected earnings and sales results for its third quarter, but recorded downbeat performance for its cloud computing unit.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.